Guangda Xiang

1.5k total citations
46 papers, 1.1k citations indexed

About

Guangda Xiang is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Guangda Xiang has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Epidemiology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Guangda Xiang's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Adipose Tissue and Metabolism (7 papers) and Biomarkers in Disease Mechanisms (4 papers). Guangda Xiang is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Adipose Tissue and Metabolism (7 papers) and Biomarkers in Disease Mechanisms (4 papers). Guangda Xiang collaborates with scholars based in China, United States and Czechia. Guangda Xiang's co-authors include Lin Xiang, Jing Dong, Mei Wen, Zhao Lin-shuang, Ling Yue, Biao Zhu, Min Liu, Junyan Lu, Lingwei Xiang and Biying Meng and has published in prestigious journals such as American Journal of Clinical Nutrition, Diabetes and Endocrinology.

In The Last Decade

Guangda Xiang

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangda Xiang China 19 432 369 221 132 131 46 1.1k
Hiroyuki Mori United States 15 619 1.4× 610 1.7× 407 1.8× 144 1.1× 239 1.8× 23 1.6k
Diti Chatterjee Bhowmick United States 10 320 0.7× 635 1.7× 403 1.8× 77 0.6× 176 1.3× 18 1.0k
Cheol Son Japan 16 261 0.6× 447 1.2× 204 0.9× 121 0.9× 150 1.1× 36 892
Ivet Elias Spain 12 312 0.7× 492 1.3× 352 1.6× 77 0.6× 94 0.7× 16 854
Niclas Franck Sweden 12 405 0.9× 397 1.1× 439 2.0× 75 0.6× 118 0.9× 16 1.0k
Yuichi Akasaki Japan 16 683 1.6× 465 1.3× 310 1.4× 80 0.6× 193 1.5× 42 1.4k
Beibei Zhu United States 10 275 0.6× 488 1.3× 515 2.3× 95 0.7× 126 1.0× 17 1.1k
Victoria Rotter Sopasakis Sweden 14 392 0.9× 435 1.2× 491 2.2× 112 0.8× 104 0.8× 25 1.0k
Carole Hénique France 17 355 0.8× 187 0.5× 205 0.9× 63 0.5× 138 1.1× 24 1.1k
Tomasz Wietecha United States 18 389 0.9× 207 0.6× 166 0.8× 156 1.2× 265 2.0× 33 1.3k

Countries citing papers authored by Guangda Xiang

Since Specialization
Citations

This map shows the geographic impact of Guangda Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangda Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangda Xiang more than expected).

Fields of papers citing papers by Guangda Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangda Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangda Xiang. The network helps show where Guangda Xiang may publish in the future.

Co-authorship network of co-authors of Guangda Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guangda Xiang. A scholar is included among the top collaborators of Guangda Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangda Xiang. Guangda Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Pei, et al.. (2025). Meteorin-like/Metrnl: A pleiotropic cytokine implicated in metabolic, inflammatory and malignant disorders. Cytokine & Growth Factor Reviews. 87. 64–72.
2.
Huang, Kai, et al.. (2024). Dietary and lifestyle oxidative balance score was negatively associated with the risk of diabetic kidney disease: NHANES 2005–2020. Acta Diabetologica. 62(6). 819–829. 1 indexed citations
3.
Xiang, Lin, Min Liu, Guangda Xiang, et al.. (2024). Dapagliflozin promotes white adipose tissue browning though regulating angiogenesis in high fat induced obese mice. BMC Pharmacology and Toxicology. 25(1). 26–26. 5 indexed citations
4.
Zhang, Junxia, Shuguang Li, Jinling Xu, et al.. (2024). Continuous intrafemoral artery infusion of urokinase improves diabetic foot ulcers healing and decreases cardiovascular events in a long-term follow-up study. BMJ Open Diabetes Research & Care. 12(1). e003414–e003414.
5.
Liu, Yan, et al.. (2024). Long-term stability of frozen platelet-rich plasma under −80 °C storage condition. Regenerative Therapy. 26. 826–830.
6.
Peng, Wei‐Xia, Ting Zhu, Guangda Xiang, et al.. (2023). Identification of signalling downstream of the transcription factor forkhead box protein M1 that protects against endoplasmic reticulum stress in a diabetic foot ulcer model. Diabetic Medicine. 40(6). e15051–e15051. 3 indexed citations
7.
Ding, Sheng, Yi Yang, Jinling Xu, et al.. (2023). Diagnostic Value of the Combined Measurement of Serum HCY and NRG4 in Type 2 Diabetes Mellitus with Early Complicating Diabetic Nephropathy. Journal of Personalized Medicine. 13(3). 556–556. 6 indexed citations
8.
Ding, Yan, Xiaoli Xu, Biying Meng, et al.. (2023). Myeloid-derived growth factor alleviates non-alcoholic fatty liver disease alleviates in a manner involving IKKβ/NF-κB signaling. Cell Death and Disease. 14(6). 376–376. 15 indexed citations
9.
Cheng, Yangyang, Ling Yue, Junxia Zhang, & Guangda Xiang. (2023). Stress hyperglycemia is associated with disease severity in COVID-19. Endokrynologia Polska. 74(5). 528–535. 1 indexed citations
11.
Xu, Jinling, et al.. (2022). Identification of Key Biomarkers and Pathways for Maintaining Cognitively Normal Brain Aging Based on Integrated Bioinformatics Analysis. Frontiers in Aging Neuroscience. 14. 833402–833402. 17 indexed citations
13.
Xu, Xiaoli, Biying Meng, Yin Sun, et al.. (2021). Neuregulin 4 Attenuates Osteoarthritis Progression by Inhibiting Inflammation and Apoptosis of Chondrocytes in Mice. Calcified Tissue International. 110(1). 131–142. 11 indexed citations
14.
Wen, Junping, et al.. (2021). Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome. Frontiers in Endocrinology. 12. 747888–747888. 35 indexed citations
15.
Wang, Li, Yixiang Li, Bei Guo, et al.. (2020). Myeloid-Derived Growth Factor Promotes Intestinal Glucagon-Like Peptide-1 Production in Male Mice With Type 2 Diabetes. Endocrinology. 161(2). 23 indexed citations
16.
Cheng, Yangyang, Ling Yue, Zhiyang Wang, Junxia Zhang, & Guangda Xiang. (2020). Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 35(2). 107809–107809. 26 indexed citations
17.
Zhu, Biao, Mei Wen, Ting Jiao, et al.. (2020). Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet. European Journal of Pharmacology. 884. 173350–173350. 23 indexed citations
18.
Xu, Jinling, et al.. (2017). Relationship between the subclinical thyroid dysfunction and the risk for fracture: A meta analysis. Zhonghua neifenmi daixie zazhi. 33(2). 103–110. 1 indexed citations
19.
Xiang, Lingwei, Hongyu Wu, An Pan, et al.. (2016). FTO genotype and weight loss in diet and lifestyle interventions: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 103(4). 1162–1170. 80 indexed citations
20.
Liu, Meilian, RuiHua Xiang, Ning Zhang, et al.. (2012). Fat-Specific DsbA-L Overexpression Promotes Adiponectin Multimerization and Protects Mice From Diet-Induced Obesity and Insulin Resistance. Diabetes. 61(11). 2776–2786. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026